A patient reports a skin rash while taking phenytoin. What is an appropriate nurse response?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

A patient reports a skin rash while taking phenytoin. What is an appropriate nurse response?

Explanation:
Skin rash from phenytoin is a potential adverse reaction that needs clinical evaluation. The appropriate nurse response is to acknowledge the rash as an adverse effect and tell the patient that the healthcare provider will follow up for further instructions. This approach ensures the reaction is assessed for severity, potential progression, and the need to adjust or switch therapy, rather than assuming it’s harmless or requiring immediate emergency action. Rash alone doesn’t automatically mean stopping the drug or calling emergency services—that decision depends on how severe it is and whether there are signs of a serious hypersensitivity reaction (such as widespread blistering, mucous membrane involvement, fever, or trouble breathing). Therefore, reporting and awaiting provider guidance is the safest next step.

Skin rash from phenytoin is a potential adverse reaction that needs clinical evaluation. The appropriate nurse response is to acknowledge the rash as an adverse effect and tell the patient that the healthcare provider will follow up for further instructions. This approach ensures the reaction is assessed for severity, potential progression, and the need to adjust or switch therapy, rather than assuming it’s harmless or requiring immediate emergency action.

Rash alone doesn’t automatically mean stopping the drug or calling emergency services—that decision depends on how severe it is and whether there are signs of a serious hypersensitivity reaction (such as widespread blistering, mucous membrane involvement, fever, or trouble breathing). Therefore, reporting and awaiting provider guidance is the safest next step.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy